We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Regeneration of Heart Tissue Induced by Cardiac Stem Cells

By LabMedica International staff writers
Posted on 09 Feb 2017
Print article
Image: Heart cells growing in rectangular, box-like scaffold made with three-dimensional printing (Photo courtesy of the University of Alabama).
Image: Heart cells growing in rectangular, box-like scaffold made with three-dimensional printing (Photo courtesy of the University of Alabama).
Nanoscale three-dimensional printing was used to create a scaffold for the growth of cardiovascular tissue that could be transplanted into a damaged heart following a heart attack.

The heart cannot normally regenerate muscle tissue after a heart attack has killed part of the muscle wall. In order to spur the damaged heart into regenerating new tissue, investigators at the University of Alabama and the University of Minnesota used multiphoton-excited, three-dimensional printing (MPE-3DP) to generate a native-like, extracellular matrix (ECM) scaffold with submicron resolution.

This novel scaffolding was seeded with approximately 50,000 human, iPSC (induced pluripotent stem cell)-derived cardiomyocytes (CMs), smooth muscle cells (SMCs), and endothelial cells (ECs) in a 2:1:1 ratio to generate the hCMP (human, iPSC-derived cardiac muscle patch). The patch began generating calcium transients and beating synchronously within one day of seeding; the speeds of contraction and relaxation and the peak amplitudes of the calcium transients increased significantly over the next seven days.

The investigators reported in the January 9, 2017, online edition of the journal Circulation Research that when tested in mice with surgically induced myocardial infarction (MI), measurements of cardiac function, infarct size, apoptosis, both vascular and arteriole density, and cell proliferation at week four after treatment were significantly better in animals treated with the hCMPs than in animals treated with cell-free scaffolds.

The authors concluded that, “Thus, the hiPSC-derived cardiac muscle patches produced for this report may represent an important step toward the clinical use of three-dimensional-printing technology. To our knowledge, this is the first time modulated raster scanning has ever been successfully used to control the fabrication of a tissue-engineered scaffold, and consequently, our results are particularly relevant for applications that require the fibrillar and mesh-like structures present in cardiac tissue.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.